Drug Shortage Report for HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG
Report ID | 138032 |
Drug Identification Number | 02125323 |
Brand name | HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG |
Common or Proper name | HYDROMORPH CONTIN |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 3MG |
Dosage form(s) | CAPSULE (SUSTAINED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2021-04-23 |
Actual start date | 2021-04-23 |
Estimated end date | 2021-06-07 |
Actual end date | 2021-06-04 |
Shortage status | Resolved |
Updated date | 2021-06-05 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-04-23 | English | Compare |
v2 | 2021-04-23 | French | Compare |
v3 | 2021-04-24 | English | Compare |
v4 | 2021-05-20 | English | Compare |
v5 | 2021-05-20 | French | Compare |
v6 | 2021-06-03 | English | Compare |
v7 | 2021-06-03 | French | Compare |
v8 | 2021-06-04 | English | Compare |
v9 | 2021-06-04 | French | Compare |
v10 | 2021-06-05 | English | Compare |
Showing 1 to 10 of 10